Related Experiment Video
Updated: Aug 9, 2025

07:12
Chronic Post-Ischemia Pain Model for Complex Regional Pain Syndrome Type-I in Rats
Published on: January 21, 2020
7.8K
CYP1B1-derived epoxides modulate the TRPA1 channel in chronic pain
Lili Sun1, Jie Zhang2, Changshan Niu3
1Department of Pharmacology and Toxicology, Center for Human Toxicology, University of Utah, Salt Lake City, UT 84112, USA.
Acta Pharmaceutica Sinica. B
|February 23, 2023
Summary
Researchers identified a new pathway involving CYP1B1, oxylipins like 8,9-EET, and TRPA1 channels that contributes to chronic pain. Targeting this axis may offer novel pain relief strategies.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Chronic pain is a significant health issue with limited effective treatments.
- Transient receptor potential (TRP) ion channels are potential targets for pain management.
- Endogenous ligands regulating TRP channels in pain and inflammation are not well understood.
Purpose of the Study:
- To investigate the role of CYP1B1 and its lipid products in chronic pain.
- To identify endogenous ligands that activate TRP channels involved in pain signaling.
- To explore the therapeutic potential of targeting the CYP1B1-oxylipin-TRPA1 axis.
Main Methods:
- Transcriptomic and lipidomic analysis of a mouse spinal nerve ligation (SNL) pain model.
- In vitro confirmation of 8,9-epoxyeicosatrienoic acid (EET) and 19,20-EpDPA production by CYP1B1.
- Functional assays using HEK-293 cells and cultured mouse neurons to assess TRPA1 channel activity.
- Pharmacological inhibition of TRPA1 and genetic knockout of Cyp1b1 in mice.
Main Results:
- SNL injury increased Cyp1b1 mRNA and led to accumulation of 8,9-EET and 19,20-EpDPA.
- These oxylipins activated and sensitized the TRPA1 channel in a dose-dependent manner.
- Cyp1b1-knockout mice showed reduced chronic pain, and 19,20-EpDPA induced mechanical hypersensitivity blocked by TRPA1 inhibition.
Conclusions:
- The CYP1B1-oxylipin-TRPA1 pathway is implicated in the development of chronic pain.
- 8,9-EET and 19,20-EpDPA are endogenous TRPA1 agonists relevant to pain.
- Targeting the CYP1B1-oxylipin-TRPA1 axis presents a promising therapeutic strategy for pain management.
Keywords:
CYP1B1Calcium imagingChronic painEpoxidesHyperalgesiaInflammationSpinal nerve ligationTRPA1More Related Videos
Related Concept Videos
Analgesia and Pain Management
705
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
705
Pain
536
Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
536
Opioid Analgesics: Synthetic and Semisynthetic Opioids
367
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
367
Opioid Receptors: Overview
1.3K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.3K
Nociception
28.2K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
28.2K
Mechanically-gated Ion Channels
6.5K
Mechanically-gated ion channels are proteins found in eukaryotic and prokaryotic cell membranes that open in response to mechanical stress. Tension, compression, swelling, and shear stress can alter the conformation of the protein, opening a transmembrane channel that allows the passage of ions for signal transmission. In eukaryotes, mechanically-gated channels are distributed in several regions like the neurons, lungs, skin, bladder, and heart, where they play critical roles in numerous...
6.5K

